Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,062 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $369.92 | 6 | $0 (2020) |
| Medtronic, Inc. | $306.14 | 7 | $0 (2023) |
| ABBVIE INC. | $94.71 | 4 | $0 (2024) |
| Medtronic Vascular, Inc. | $88.64 | 3 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $47.89 | 3 | $0 (2021) |
| Relypsa, Inc. | $35.47 | 2 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.73 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $21.85 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $14.68 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.72 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94.71 | 4 | ABBVIE INC. ($94.71) |
| 2023 | $136.54 | 4 | Medtronic, Inc. ($136.54) |
| 2022 | $169.60 | 3 | Medtronic, Inc. ($169.60) |
| 2021 | $23.37 | 2 | Janssen Pharmaceuticals, Inc ($12.23) |
| 2020 | $126.70 | 5 | Medtronic Vascular, Inc. ($88.64) |
| 2019 | $156.59 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($98.95) |
| 2018 | $14.93 | 1 | Relypsa, Inc. ($14.93) |
| 2017 | $339.31 | 9 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($249.31) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/17/2023 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $64.52 | General |
| Category: Stents | ||||||
| 12/15/2023 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Stents | ||||||
| 09/08/2023 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Stents | ||||||
| 06/02/2023 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $45.71 | General |
| Category: Stents | ||||||
| 12/16/2022 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Stents | ||||||
| 12/16/2022 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Stents | ||||||
| 01/29/2022 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $129.00 | General |
| Category: Stents | ||||||
| 06/30/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: COVID-19 | ||||||
| 04/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2020 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $53.80 | General |
| Category: Stents | ||||||
| 07/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2020 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Stents | ||||||
| 03/11/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/06/2020 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Stents | ||||||
| 10/09/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/30/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: RESPIRATORY | ||||||
| 01/16/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $98.95 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/26/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Hyperkalemia | ||||||
| 09/28/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 260 | 370 | $66,394 | $22,865 |
| 2022 | 8 | 335 | 447 | $72,069 | $27,398 |
| 2021 | 7 | 381 | 515 | $81,538 | $32,215 |
| 2020 | 10 | 543 | 640 | $96,284 | $36,743 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 118 | 225 | $34,980 | $13,253 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 62 | 64 | $11,931 | $4,121 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 34 | 34 | $10,536 | $3,261 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 26 | 26 | $6,430 | $1,329 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 21 | $2,517 | $901.00 | 35.8% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 91 | 151 | $21,744 | $7,752 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 52 | 52 | $13,728 | $5,212 | 38.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 96 | $12,288 | $4,977 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 68 | 69 | $11,799 | $4,839 | 41.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 18 | $3,312 | $1,408 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 30 | 33 | $3,729 | $1,250 | 33.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,596 | $1,048 | 40.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 17 | 17 | $2,873 | $911.35 | 31.7% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 127 | 215 | $30,960 | $11,687 | 37.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 57 | 57 | $15,048 | $5,982 | 39.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 47 | 87 | $11,136 | $4,700 | 42.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 52 | 57 | $9,747 | $4,319 | 44.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 50 | 50 | $8,450 | $2,951 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 37 | 38 | $4,294 | $1,800 | 41.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 11 | 11 | $1,903 | $776.40 | 40.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 130 | 198 | $25,344 | $11,173 | 44.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 65 | 65 | $17,160 | $5,944 | 34.6% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 79 | 97 | $13,968 | $5,453 | 39.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 69 | 69 | $11,661 | $3,571 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 58 | 60 | $10,260 | $3,496 | 34.1% |
About Dr. Allison Roe, D.O
Dr. Allison Roe, D.O is a Hospitalist healthcare provider based in Saint Joseph, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1497015705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allison Roe, D.O has received a total of $1,062 in payments from pharmaceutical and medical device companies, with $94.71 received in 2024. These payments were reported across 33 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,062).
As a Medicare-enrolled provider, Roe has provided services to 1,519 Medicare beneficiaries, totaling 1,972 services with total Medicare billing of $119,221. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Hospitalist
- Location Saint Joseph, MO
- Active Since 05/21/2012
- Last Updated 10/09/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1497015705
Products in Payments
- LifeVest (Device) $369.92
- RESOLUTE ONYX (Device) $306.14
- Resolute (Device) $88.64
- DALVANCE (Drug) $70.18
- XARELTO (Drug) $47.89
- TEFLARO (Drug) $36.72
- Veltassa (Drug) $35.47
- RELISTOR (Drug) $31.73
- LANTUS (Drug) $21.85
- ENTRESTO (Drug) $14.68
- SPIRIVA RESPIMAT (Drug) $13.72
- ELIQUIS (Drug) $13.67
- Veklury (Drug) $11.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Saint Joseph
Dr. Steffan Libarnes, M.d, M.D
Hospitalist — Payments: $777.57
Michael Wang, Md, MD
Hospitalist — Payments: $632.14
Nafis Islam, Md, MD
Hospitalist — Payments: $616.46
Daniel Bosis, M.d, M.D
Hospitalist — Payments: $381.62
Aadil Ahmed, Do, DO
Hospitalist — Payments: $365.53
Dr. Amulya Dakka, Md, MD
Hospitalist — Payments: $292.64